Clinical Trials
9 trialsNCT02104011 2026-05-19
STBETA
University Hospital, Bordeaux
Phase 2 Completed
NCT05561751 2026-02-12
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
GPCR Therapeutics, Inc.
Phase 2 Completed
NCT05679193 2024-05-29
PeP-RALP
Oslo University Hospital
Phase 2 Completed
NCT02641314 2024-05-10
METRO-NB2012
University of Cologne
Phase 2 Completed
NCT04518124 2023-11-22
Propranolol in Angiosarcoma
The Netherlands Cancer Institute
Phase 2 Completed
NCT03589014 2022-02-25
Treat_CCM
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT01847001 2021-09-10
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Columbia University
Phase 2 Completed
NCT02420223 2021-06-07
Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients
Medical College of Wisconsin
Phase 2 Completed
NCT01072045 2014-12-02
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
University of Sao Paulo
Phase 2 Completed